Halofantrine in acute malaria.

dc.contributor.authorLazar, A Ien_US
dc.date.accessioned1994-05-01en_US
dc.date.accessioned2009-05-31T03:29:41Z
dc.date.available1994-05-01en_US
dc.date.available2009-05-31T03:29:41Z
dc.date.issued1994-05-01en_US
dc.identifier.citationLazar AI. Halofantrine in acute malaria. Journal of the Association of Physicians of India. 1994 May; 42(5): 425-6; author reply 426-7en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/93950
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAcute Diseaseen_US
dc.subject.meshAntimalarials --therapeutic useen_US
dc.subject.meshDrug Resistance, Multipleen_US
dc.subject.meshHumansen_US
dc.subject.meshMalaria, Falciparum --drug therapyen_US
dc.subject.meshMalaria, Vivax --drug therapyen_US
dc.subject.meshPhenanthrenes --therapeutic useen_US
dc.subject.meshPrimaquine --therapeutic useen_US
dc.subject.meshRecurrenceen_US
dc.titleHalofantrine in acute malaria.en_US
dc.typeCommenten_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: